WELCOME TO C-PATH!
MISSION:
C-Path creates innovative collaborations in research and education that enable the safe acceleration of the process for developing new medical products.
VISION:
C-Path will be an independent non-profit institute that serves as a "trusted third party" enabling scientists from the FDA, academia and industry to work together for the public good.
Whats New?
Reader's Digest's Big Ideas to Fix Healthcare!
Reader's Digest names C-Path as No. 7 out of 18 big ideas to fix healthcare now! (read article)
New testing Methods!
FDA and EMEA conclude that seven new renal safety biomakers qualified by C-Path's PSTC are appropriate for use in specific regulatory settings.
What We Do and Why We Do It
The Critical Path Institute (C-Path) is an independent, non-profit organization uniquely dedicated to implementing the FDA's Critical Path Initiative by creating collaborations among regulators (scientists from the FDA) and the regulated (medical product industry) that result in accelerated development of safe, new medical products.
A wake-up call: In a 2004 white paper now known as the Critical Path Initiative, the FDA called attention to an alarming decline in the number of innovative medical products being submitted for FDA approval. Click here for more information.
The Institute's Role as a Neutral Third Party
The Critical Path Institute's mission from the beginning has been to serve as a "trusted third party" to enable innovative collaborations between government regulators, the academic community and regulated businesses to come together to improve the process of developing new medical products, making the process faster, safer, smarter.